News | May 27, 2022
DFE Pharma opens its new Center of Excellence in Hyderabad, India
The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs
The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs
The AI and technology upgrades allow doctors to choose their medical speciality and even spelling preferences to set their own speech model
The aim is to provide further insights into patients' lives in the effort to deliver better outcomes for people with psoriatic arthritis (PsA)
New block enhances the company's global capabilities in Oral Solid Dosage (OSD) Forms, increasing total plant capacity to 4.5 billion doses
The study was conducted in equal laboratory conditions in the Spallanzani Institute in Italy on comparable sera samples from individuals vaccinated with Sputnik V and Pfizer with a similar level of IgG antibodies and virus-neutralizing activity (VNA) against Wuhan variant.
Dr Rupali Paranjape, an experienced regulatory and compliance consultant and author of Blue Ocean of Compliance shares insights on her book in an interview with Thomas C Thottathil, Editor, www.indianpharmapost.com
Researchers have found out that myopia often leads to an abnormal increase in axial length. When the axial length grows to more than 25mm, especially with age, problems like cataracts or glaucoma can appear
The company will invest approximately €440 million to increase membrane manufacturing capacity in Carrigtwohill and to build a new manufacturing facility at Blarney Business Park, both in Cork, Ireland
Investment with representation on the Board of Directors and technical know-how
The Portal BioRRAP will cater to all those seeking regulatory approval for biological research
Subscribe To Our Newsletter & Stay Updated
